To validate the relationships between PDAI5 and immune pathways in cancers, we investigated the effect of PDIA5 on the programmed death-1 (PD-1)/PD-L1 signaling pathway and SPP1 signaling pathway. The gene discussed is CD274; the disease is cancer.